|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Diabetic retinopathy-ocular complications of diabetes mellitus显示文摘In industrialized nations diabetic retinopathy is the most frequent microvascular complication of diabetes mellitus and the most common cause of blindness in the workingage population.In the next 15 years,the number of patients suffering from diabetes mellitus is expected to increase significantly.By the year 2030,about 440 million people in the age-group 20-79 years are estimated to be suffering from diabetes mellitus worldwide(prevalence 7.7%),while in 2010 there were 285 million people with diabetes mellitus(prevalence 6.4%).This accounts for an increase in patients with diabetes in industrializednations by 20% and in developing countries by 69% until the year 2030.Due to the expected rise in diabetic patients,the need for ophthalmic care of patients(i.e.,exams and treatments) will also increase and represents a challenge for eye-care providers.Development of optimized screening programs,which respect available resources of the ophthalmic infrastructure,will become even more important.Main reasons for loss of vision in patients with diabetes mellitus are diabetic macular edema and proliferative diabetic retinopathy.Incidence or progression of these potentially blinding complications can be greatly reduced by adequate control of blood glucose and blood pressure levels.Additionally,regular ophthalmic exams are mandatory for detecting ocular complications and initiating treatments such as laser photocoagulation in case of clinical significant diabetic macular edema or early proliferative diabetic retinopathy.In this way,the risk of blindness can considerably be reduced.In advanced stages of diabetic retinopathy,pars-plana vitrectomy is performed to treat vitreous hemorrhage and tractional retinal detachment.In recent years,the advent of intravitreal medication has improved therapeutic options for patients with advanced diabetic macular edema. | Martin M Nentwich Michael W Ulbig | 2015 | World Journal of Diabetes2015，6，3： | 44 |
| 2 | In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment显示文摘 | Kernt M Neubauer AS Ulbig MW | 2008 | J Cataract Refract Surg2008，34，3： | 1 |
| 3 | Reso- lution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane 显示文摘 | Gandorfer A Messmer E M Ulbig M W | 2000 | Retina2000，20，： | 1 |
| 4 | Determination of an Amount of Gas by Weighing under Vacuum Conditions and Uncertainty Analysis 显示文摘 | Wenz P Ulbig P Sarge S M | 2003 | Journal of Thermal Analysis and Calorimetry2003，71，1： | 1 |
| 5 | Resolution of Diabetic Macular Edema after Surgical Removal of the Posterior Hyaloid and the Inner Limiting Membrane显示文摘 | Gandorfer A Messmer E M Ulbig M W | 2000 | Retina2000，20，2： | 1 |
| 6 | Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy显示文摘 | Gandorfer A Putz E Welge-Lussen U Gruterich M Ulbig M Kampik A | 2001 | Br J Ophthalmol2001，85，1： | 1 |
| 7 | Plasmin-assisted vitrectomy eliminates cortical vitreous remnants显示文摘 | Gandorfer A Ulbig M Kampik A | 2002 | Eye(Lond)2002，16，1： | 1 |
| 8 | Diabetic mtinopathy-ocular complications of diabetes mellitus显示文摘 | Nentwich M M Ulbig M W | 2015 | World J Diabetes2015，6，3： | 1 |
| 9 | Macular hole size as a prognostic factor in macular hole surgery显示文摘 | Ullrich S Haritoglou C Gass C Schaumberger M Ulbig MW Kampik A | 2002 | Br J Ophthalmol2002，86，4： | 1 |
| 10 | Diabetic retinopathy:early diagnosis and effective treatment显示文摘 | KOLLIAS A N ULBIG M W | 2010 | Dtsch Arztebl Int2010，107，5： | 1 |
| 11 | Diode laser photo-coagulation diabeltic macular dedma显示文摘 | Ulbig M W Mc Hugh D A Hamilton AMP | 1995 | BR J Ophthalmol1995，79，： | 1 |
| 12 | Maculax hole size as a prognostic factor in macular hole surgery显示文摘 | Ullrieh S Haritoglou C Gass C Schaumberger M Ulbig MW Ka- mpik A | 2002 | Br J Ophthalmo12002，85，4： | 1 |
| 13 | Determination of an amount of gas by weighing under vacuum conditions and uncertainty analysis 显示文摘 | Wenz P Ulbig P Sarge S M | 2003 | Journal of Thermal Analysis and Calorimetry2003，，71： | 1 |
| 14 | Vitreoretinal morphology of plasmin-treated human eyes显示文摘 | Gandorfer A Priglinger S Schebitz K Hoops J Ulbig M Ruckhofer J | 2002 | Am J Ophthalmol2002，133，1： | 1 |
| 15 | Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy显示文摘 | Gandorfer A Putz E Welge LU Gruterich M Ulbig M Kampik A | 2001 | Br J Ophthalmol2001，85，1： | 1 |
| 16 | Plasmin-assisted vitrectomy eliminates corticalvitreous remnants显示文摘 | Gandorfer A Ulbig M Kampik A | 2002 | Eye2002，16，： | 1 |
| 17 | Non-mydriatic wide field fundus photography in bilateral serous retinal detachment due to HELLP syndrome显示文摘 | MAYER W J HAKIM I ULBIG M W | 2012 | Archives of Gynecology and Obstetrics2012，286，3： | 1 |
| 18 | Plasmin-assisted vitrectomy eliminates cortical vitreous remnants显示文摘 | Gandorfer A Ulbig M Kampik A | 2002 | Eye (Lond)2002，16，： | 1 |
| 19 | Intracameral injection of bevacizumab for the treatment of neovascular glaucoma 显示文摘 | Woff A Von Jagow B Ulbig M Haritoglou C | 2011 | Ophthalmologica2011，225，2： | 1 |
| 20 | Clinical comparison of semiconductor diode laser versus neodymium : YAG noncontact cyclophotocoagulation 显示文摘 | Ulbig M W McHugh DA McNaught AI | 1995 | Br J Ophthalmol1995，79，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员